Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model: Application to a Population of US Adult Smokers

Author： Howard Paul  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.26, Iss.6, 2008-01, pp. : 497-511

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan

By Igarashi Ataru  

PharmacoEconomics, Vol. 27, Iss. 3, 2009-01 ,pp. : 247-261

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Varenicline in Belgium, Compared with Bupropion, Nicotine Replacement Therapy, Brief Counselling and Unaided Smoking Cessation: A BENESCO Markov Cost-Effectiveness Analysis

By Annemans Lieven  

Clinical Drug Investigation, Vol. 29, Iss. 10, 2009-10 ,pp. : 655-665

Adis International

Access to resources Recommend Favorite

A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease

By Lock Kevin   Wilson Koo   Murphy Daniel   Riesco Juan Antonio  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. : 2613-2626

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population study

By Kotz Daniel   Brown Jamie   West Robert  

Psychopharmacology, Vol. 231, Iss. 1, 2014-01 ,pp. : 37-42

Springer Publishing Company

Access to resources Recommend Favorite

A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data

By Xenakis James G.  

PharmacoEconomics, Vol. 29, Iss. 6, 2011-06 ,pp. : 497-510

Adis International

Access to resources Recommend Favorite